Hi guys, how you doing? I am your host Rich here and we have a RichTV live with our very special guest, Araz Azadian, the CEO of Avikana. How you doing today Araz? Doing well. How are you? I'm doing fantastic. Thank you for joining us today. Excited to have you on the show. And I wanted to start off by asking you, why don't you tell us a little bit about Avikana and what made you want to become the CEO? Sure. So I'm the founding CEO. So I think it started with me wanting to create the company then to be the CEO. I had two co-founders. We came from different walks of life. One was a patient advocate looking at cannabinoids as medicine and the other one said to period who's the president was an attorney with a fond understanding of the regulations. We started the company 2015 with the vision of providing standardized medicine using cannabinoids. My background prior to that, I was in the biotech sector, I was a management consultant. I was an executive in a couple of biotech companies and learned how biotech or biopharma company functions. And when I saw the cannabis opportunity, I realized that all the companies that were there, the initial, let's say the big four or five, were really predominantly focused on cultivation and lead, where I knew that the ultimately standardized medicine data evidence to educate physicians and to provide patients with the right methods and the right products is going to be the massive market opportunity. And we started with that vision. And considering my qualifications as a biotech executive, the three of us decided that it would make the most amount of sense for me to be the CEO. I basically took the huge leap of faith and we accepted the company together. Now, you mentioned this a little bit. What are the main focuses of Avicana Inc for the first half of 2021 and some of the milestones the company has already set to achieve? So when we started off in 2015, the idea was to take a traditional drug development process. So your GW pharma, you know, drug development optimization, preclinical clinical development, and we did that, you know, we were part of a Johnson and Johnson incubator, where the only cannabis company that has ever been admitted to that. So we're inside J&J's research center, we have our own cannabis research places. It's all pharma and, you know, about two years into it, when we started developing these more advanced drugs, tablets, capsules, transdermal patches and topicals, we realized that the drug development clinical development pathway, which we're taking and we're still doing, is a long journey. But our expertise, which is really advanced cannabinoid standardized medicine, actually has faster to market channels, which is medical cannabis, cosmetics. So we started developing more products for today's market. And we are today in 2021, we have our medical line commercial in the largest pharmacy chain in Canada, Shoppers Drug Mart. We're selling them in Latin America and Colombia. We have our cosmetic line commercial in a couple of countries. And our pharmaceutical drugs, which when we started off from, are actually progressing and are they're being registered in many countries as well. So really, we are a recently commercialized biotech biopharma company that has specialized in cannabinoid based medicine. And we've established what we believe is the most strong or the most comprehensive scientific platform related to cannabinoid based medicine in the world today. Wow, that's impressive.  And only the first time we got a chance to meet and I haven't heard much about your company yet. So I'm very excited about learning more and having our entire community really start syncing their teeth in and learning more about your company. Now the cannabis space is starting to really pick up. And now that the possible legalization in America is coming, Q, tell us what sets Avicana Inc apart from the rest? So we're a biotech biopharma company that works with cannabinoids. We're not a cannabis company. So I don't sell joints. I don't sell pre-rolls. I'm not a multi-state operator. We trade on the TSX as a biotech company, not as the cannabis company. So the opportunity that is opening up in the United States is I believe a lot bigger than what people actually perceive. So if you're a multi-state operator, that means you can cross borders and get access to capital and you can sell more joints and pre-rolls and stuff like that. Great opportunity and I'm completely fond of that and I believe in that. But that's a recreational company. For the medical, the biotech, the pharma companies, the advancements in the United States means better access to capital, means more sophisticated investors that believe in biotech and biopharma benefits of cannabinoids. And GW Pharma got acquired last week for $8 billion. I mean the timing is great. This also means that big pharma is going to get a little bit more comfortable in getting involved with cannabis companies that are doing the biotech and biopharma stuff. So I think for companies like us that have spent five years establishing a scientific platform, have demonstrated our ability to take concept, develop it in the lab, optimize it, do this clinical studies, then commercialize it. Companies like us that have demonstrated that now become targets for funds, institutions, pharmaceutical companies that are seeking to enter the space. And because in Canada it's federally legal and we have the federal licenses to do this research, we believe we're in the forefront of that. We are the intellectual property that big pharma will start to look for, to collaborate with or to acquire. So I think the opportunity towards legalization or decriminalization in the United States has benefits for the multi-state operators, but also has substantial benefits for the biotech, biopharma companies. Very exciting. I like what you guys are doing. It's very unique. And you guys are focused on the medicinal side. You guys are focused on the research side. You're not focused like you said on joints. I don't like that. You're not touching the plant, correct? We actually are vertically integrated in Colombia. So I'm cultivating organic, sustainable, low cost, but all of that input material gets processed into what we call APIs, active pharmaceutical ingredients, CBD, CBG, THC, and then that goes into our finished drugs. So we don't sell flour, but we do have vertical integration and we've built that in a developing country in an organic, sustainable way so that we can maintain the quality and the cost that we need to supply the rest of the world. The entire world is pretty excited about the benefits of cannabis from a medicinal perspective. And I think as investors, as an investment community, we're often distracted by recreational use or adult use, which is predominantly can in the United States. But outside of that, adult use and recreational is not legal anywhere else. There's a Uruguay, but that's a very small country. So really, the big time global opportunity for advanced medicine with cannabinoids is really a global opportunity. And that's what we focus on. So Colombia gives us access to low enough cost input material so that when I have a bottle of capsules or tablets or topical that has cannabinoids, we're talking 10, 20, $30 products, not hundreds of dollars a product. So yes, we are vertically integrated, but still it's focused on medicine and evidence-based approach. Now it's vital when our community is looking at investing in stocks and in companies like yours that are early stage, undervalued, underappreciated, under exposed opportunities, that we get a good chance to understand who's behind the team. So can you tell me a little bit about the team at Avicana and what the key members bring to the table? Absolutely. I think one of the most unique things about this team is that it's the same executive team from the beginning. So I'm a biotech executive. We have lawyers, clinicians, R&D scientists. There's overall about 10 full-time employees that are MDs or PhDs in this company, and we're a very relatively small company. So this is a very professional centric, science centric company, and it's the same core team. So said to his co-founder, he's an attorney. Our head of R&D, France, he's developed a lot of the formulations and the technologies we're using. Carolina is leading our medical and clinical programs. Our head of marketing Yvonne has been with us from the beginning. Lucas leads our operations in South America. He's Argentinian. He's been there from the beginning. So the team is the same core team from the beginning, all professionals. And what's remarkable is how tightly held not only has the team been, but our shares. We've only issued 30-something million shares. It's all been strategic partners, which includes some large pharmaceutical companies, including Tasti Pharma in China and some important funds in Brazil and the States. None of the management I've ever sold shares ever. And I think that's very important that we do believe in what we've established. We're starting to see more and more credibility amongst the medical community in Canada, but also amongst the cannabis community globally, that we are the intellectual property company. So I think we're all very proud of what we've accomplished, and it's because the team has really stayed true to that vision of evidence-based cannabis medicine and has stayed together along the pathway. Now, you mentioned your share structure. That is vital for our community. We love tight float stocks. Can you break down your share structure? How much is held by insiders and institutions? I think about 40 percent is still held by the management and board, which is really important. The three co-founders probably still about own probably about 30 percent. Again, we haven't been very dilutive. And then there's several institutions, some Canadian funds, a couple of Brazilian funds, Tocely Pharma in China. There's a couple of big pharma shareholders. I think if I was to estimate, I would say 75, 80 percent of the company is very tightly held. Wow. So it's a very tight float. And you mentioned you've never sold a single share since you've been involved in the company. Myself, the rest of the senior team, never. Obviously, we have to disclose as we do. So it's online. Anyone can see it. We really believe in what we've built. We believe we're substantially undervalued because until, as a recently, people didn't really know the value of biotech pharma. Everyone thought cannabis is just joints. And now more and more evidence is coming. We are proving that as well. We have clinical collaborations with the most important hospitals and academic institutions in Canada. We've had that for years. So finally, we're starting to get a little bit of credit for that, where three, four years ago, everyone would always ask me, why are you doing all this research? Why are you doing that? Why don't you just grow weed and sell it? And that's not what we do. Our effort and our time was spent in putting up more advanced medicine. What's exciting for me and my shareholders today is that we are not commercial. So for a biotech company to become commercial, it's a lot more complicated. It's a longer path than for a company that grows weed, puts it in a bag and sells it. And the fact that we are not commercial means we've passed very important milestones from a regulatory perspective. And we're commercial in several countries. So it's a very, very exciting time for us. If there was one thing you would want shareholders to know about Avicana, what would it be? We're dedicated to setting the standards for what medical cannabis or medicine from the source of cannabinoids is meant to be at a global level. And we have done our homework. We've stayed committed to that. We stayed true to that. And they will see the results of that at a global level in a very, very short period of time. And what is the best way for shareholders to get in contact with you? We're going to have this video shown all over the world to investors that are watching within our community in about 100 countries. What would be the best way for them to reach you or the company if they're interested in making an investment, maybe a joint venture partner, maybe an LOI, someone has some interest? What's the best way for them to reach you? The PG 13 way is of course info at avicana.com or IR at avicana.com. You can find me on LinkedIn. My team is trying to convince me to get Twitter because I'm apparently very opinionated and people want to hear that. So for now, LinkedIn is the easiest way to reach me. Okay, great. Well, thank you so much for your time today. Araz Azadian, the CEO of Avicana. Super excited to have you on the show today. Guys, remember Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence. Always do your research before you invest in anything that we talk about here in Rich TV Live. Consult a financial advisor. Chances are if you consult a financial advisor about Avicana, they're going to say, hmm, that's a really nice pick. I really like what I see about this company, guys. Symbol in Canada, A-V-C-N. Symbol in America, A-V-C-N-F. And symbol in Frankfurt, Germany, O-N-N. If you're not winning, you're not watching. We bring in the winners and we bring them to you first. Put this pick on your radar, put on your watch list. If you like the video, smash the like button, comment down below, share the video everywhere, and subscribe. All right, Araz, thank you so much for your time today. Keep up the great work and I hope to have you on the show again one time in the future. Thank you. Thanks for having me. Keep up the great work and we'll be watching. Thank you for watching, everybody. Have a nice day.


Secretary of the Navy Ray Mavis re-enlisted 90 sailors at Pekko Park during a San Diego Padres game and was honored to share their experience and understanding with the San Diego community. Tonight when I'm doing a re-enlistment for 90 sailors, those sailors are going to be America's away team. When they're doing their job they're going to be a long way from home but getting the chance to show people their sailors, their marines and just how good a job they do. In front of thousands of fans, sailors stood at attention and recited the oath to extend their time in the Navy. We have a number of sailors who request to have their re-enlistment ceremonies here at the park and it makes us pretty proud that they'll use our platform to have their ceremony and it helps San Diegans understand how much San Diego means to our sailors. Reporting from San Diego, I'm Petty Officer Carlos Vasquez-Desec.


that's true Uh-oh, we've got a new series here. That's right. I'm gonna be doing Mega Man x2 Got pretty burnt out on Robotrek and like I said at the beginning of that let's play it's Gonna be one I'm gonna be going back to frequently You know to do five episodes here ten episodes there, but in the meantime all the maverick hunters or something Yeah, this time it's dr. Cain no more dr. Light I guess Big backstory here for Mega Man x2 Of course, you can skip all this The the overall history between Mega Man. There's like different. It's it's almost like it's a comic book series that you find with Like Marvel or DC where it's like Jesus Christ It's so overwrought with so many different timelines and different Versions and different things. It's like it's hard to keep track of and it's easy to get burnt out and just be like whatever I forget all of it Yeah, here we are with Mega Man x2 and it's yeah, this is one of those games that has one of those special chips I can't remember the name of it off the top of my head, but it's got the the wire 3d Effect going on there. First thing you want to do is I've changed dash to R Um you keeping dashes a is super awkward to me So if I switch the dash to R, that's much easier Much easier because you start the game with the ability to dash which is really really really nice Immediately we're met with a really cool opening scene here Action right off the bat. They knew what they were doing with Capcom.  I love it This is gonna be a little tough for me because I'm not sure what to say, you know Number one, it's gonna be a little hard to talk while I'm playing Mega Man And number two, I'm not sure what quite to say In between a Mega Man, I guess I can talk about my own personal experience with Mega Man I mean I Didn't have a Nintendo growing up. I had we had an Atari 2600 when I was very little it was my sisters my older sisters and And You know it was it was one of those deals where my parents did not want to get a Nintendo for me just you know We didn't have that much, you know, we were middle-class, but we didn't have that much money But you know they to them the Atari 2600. It's like it's only 10 years old Why would you want to get rid of it now? You know, it's we've barely got no money's worth from it So we never did get an NES and that's fine because I had friends that lived down the road from me That played it And here we have our first boss Whoops How do I get that? Oh, I gotta go all the way over here to climb up to Oops Yeah, really easy boss just four charge shots and he's dead anyway, I Bring that up because my minimal in my minimal exposure to the NES Mega Man very quickly became my favorite Games gaming franchise particularly Mega Man 3 stood out to me as Being really good. I'm not sure why that one I think it's because that there was a certain issue of Nintendo power that's I had all the Hit that had a hit chart for what weapon Yeah, here we've obviously got silhouettes of the villains here talking about talking smack about Mega Man Mega Man X in particular But yeah, just the straightforward nature of Mega Man always And the fact that there was kind of a quote-unquote science behind it like This weapon takes this many shots to beat this boss and this weapon takes this many shots to beat this boss I really like that as a kid. I still like it now so When I got a Super Nintendo Christmas in 1991 the first I was on pins and needles waiting for a Mega Man games So yeah needless to say I rented Mega Man X Mega Man X 2 Mega Man X 3 all the time and Mega Man X 2 over time It's become my favorite and here we go. We're we're past the intro stage One thing this game does not have is it doesn't have that cool like You know where you can flip between There's not a lot of information on the boss stages Like the first game where it gives you like stats and stuff like that But anyway, we want to start with wire sponge Why I'll show you right away The wall on the left just climb up it and there is a heart piece right there so right off the bat you get extra You get an extension of your life meter Insert joke here anyway One thing I want to ask the commenters of course. I'm recording this like back in what is today. It's the first week of March I'm not sure when this will even get posted But those glass beams I or those glass orbs that thing over there that I just I just missed the jump there What significance to those have and doesn't matter if you break those or not oops I'm trying to get my footing here. There we go Not sure what the point of breaking those is they appear to control the weather on the surface like that would make sense like the weather would would Normalize, you know, obviously, it's raining and it's windy We got our first energy tank there So yeah, I would that would think that would be the significance there, but it's obviously, you know, it's not the case damn it Dash and then blow them up and dash to get out of there Yeah, I'm not the best let's play commentary guy obviously Not entirely sure what to say when playing a game like this other than just rambling about nothing Sorry. Oh, I forgot about these things. Oh Those go away eventually cool. Oh There we go. Yeah, I guess there's not much else to say other than Why I think this game is better than Mega Man X that's seemed to annoy a few people Mega Man X I'll make no bones about it. It's got better level design and it's got I Think it's got a little bit better. Geez.  It's got a little bit better Weapons boss weapons to you to pick from and to use like I think they're a little more fun Oh There we go. I think they're a little more fun to use the boss weapons in this game are okay The level design of this game is still good, but it's not near let Mega Man X but the two things that I point it like I pointed out in my review that's a Are are really fun about this game number one is the mid-air dash. It's the leg upgrade in this game There we go. We can farm for life a little bit Get that get some life in the the old energy tank Number two is yeah, I'm not getting anything from this guy number two is that The supercharged Arm cannon that you get is is really awesome and really satisfying to use and Just a lot of fun. It's it's basically what I love about the Mega Man series It's just the pure satisfaction I'm just annihilating these robotic things. I Don't know. That's just me Let's get some life in the the old Tank, sorry if I'm boring you with life farming here, but it's just what I do here That's a little click there that little beep when you click when you pick up a life that indicates that it is your Your thing filling up I'm not getting any luck now. Oh, there we go. I think that should be enough I think that should be at least halfway with the energy tank Yeah, that's about halfway that'll work Onto Wire sponge here. It's always a little intimidating taking on a boss in Mega Man and then one of the Mega Man X games without It's weakness without its weapon.  I don't know if I can do this, you know But oh Shit out of the way. I almost got him halfway down Look out Yeah, that's what he does.  I haven't had to use my energy tank yet ouch Don't rush either. It's uh-oh. He's mad. He's angry. Anyway, don't rush through these boss fights It's easy at least for me. It's easy to feel like you need to like beat this guy ASAP and like really take advantage of every Opportunity you have but really there's no time limit here. Just take your time pick your spots Concentrate on dodging and then take taking it, you know, he's only got one thing left I should be able to take care of him here There we go That's more like it. So there we go our first boss in the bag Let's see what kind of weapon we get We get nice little fanfare music and then the same little pose as Mega Man X I got the strike chain and we're gonna use that to beat the wheel gator next time. Thanks for watching Have a great rest of your day


Hello, hello everyone. My name is Steven Augustus and I am one of your co-chairs for KubeCon Cloud NativeCon and A Virtual. I'm here to talk to you about the Kubernetes project and we're going to do some project updates. So let's jump into it. Now the Kubernetes project is comprised of people and we believe in and we care deeply for the people that work on this project day to day. I think it would be impossible to talk about what we did for the year without talking about the 2020 of it all. Now our response initially to COVID, to dealing with kind of shifting, for a lot of people shifting the way they worked, shifting the way they interacted with people and moving towards more virtual content, moving towards less meetings when possible, being more accommodating about time zones, about families. So hat tip to everyone in the project that really is involved, sub-project owners, CIG chairs and technical leads, committee members who were incredibly present and conscious about how people are kind of coping with everything that's going on in the world. And to that you may be familiar with the Kubernetes.io website and we put up a banner on the website to clearly disclaim that racism is unacceptable, it's not something that we tolerate in the project. We believe deeply in our code of conduct and enforcing it to protect the members of this project. So again hat tip to all of the folks that actually worked on applying the ability to give our website banners, the steering committee for working with me on the messaging and delivering that and holding the line. I think that it's very easy for statements that can be deemed to be political to attract trolls and we had our fair share of that. So again hat tip to everyone involved, code of conduct, committee, steering committee, contributor experience for taking on that burden, for feeling it necessary and important to speak about something that's not a political issue, something that is a human issue. So the chairs and technical leads, we recently spun up, it's not recently anymore, it's been quite some time now, spun up chair and technical lead meetings. So giving an opportunity for all of our leadership across the project to sit down, chat in a safe space to exchange ideas without any kind of the blameless retrospectives and having that safe space to create ideas that you may not feel comfortable sharing publicly. Now we also started the annual report process, so the steering committee kicked that off. The annual reports essentially starting with the working groups, having annual check-ins for each of these governance groups, giving us an opportunity to get a better feedback loop between the groups that exist in our community and the wider community. It's very easy to kind of operate in a vacuum if you don't have the chance to speak about all the accomplishments that you've been doing and also spread that out to the community. So great work there. All of the moderators again going back into just handling all of the various properties that we own across Twitter, across the website, across discuss, hat tip to everyone, YouTube, Zoom for making everything that we do safe to do and welcoming. Now speaking of Twitter, we've added the Kate's contributors Twitter handle, which is handled by contributor experience and the marketing sub-project of contributor experience. So very awesome to see us being able to publish updates about the community more frequently to the wider internet. Now the triage cap which popped up, now we have made a lot of improvements in how we kind of decreased the burden for you to maintain your areas. And I think part of it was introducing this triage cap, something that we discussed for quite some time to get some of the finer details worked out and apply the automation to the process. So hat tip to everyone that was involved there across contributor experience as well as the enhancements sub-teams and sub-project of CIG architecture. The ingress enhancement went GA, super exciting, long-standing enhancement that has been in beta and it is one of our earlier enhancements. So great to see the work around delivering that to general availability. From the GitHub management side, the GitHub administration management team has been hard at work deprecating the Kubernetes incubator org, all of the projects that are involved in that org, some of them that may have been, may no longer be maintained. We built something bigger and better and it lives somewhere else now, so kind of wrangling all of that information and kind of bringing us to the sunset of the incubator org. Now for some CIG-specific updates, we have CIG usability. CIG usability has been driving a user research study that has gotten some really great data to crunch on and that will be part of their CIG update during the conference. So hat tip to them for one forming over the last year as well as all of the work that they have done to better understand the people who consume Kubernetes day-to-day. From CIG multi-cluster, the multi-cluster service APIs are in progress. They're currently alpha. They represent some solid progress towards normalizing multi-cluster deployments and making the next level of Kubernetes operations more manageable. That's definitely something that we consider with having all of these disparate environments. So hat tip to CIG multi-cluster. From the storage side, the container object storage interface was released for both block and file, CATE storage being able to build a similar interface for object storage is also coming. PSE is inbound for that so we should see that soon. Generic ephemeral volumes were progressed across the last few cycles. CSI support for Windows, which is a huge step forward for Windows support on Kubernetes overall. The volume snapshot feature is also progressed. So moving into CIG docs, CIG docs did an awesome job on the website migration, more modern theme, easier to maintain for their contributors. And on the architecture side, the production readiness sub-project as well as the PRR reviews as part of CEPs are now making their way into the release cycle. From the CIG release side, we've been working on tooling to make our lives easier, to make your lives easier, to make it easier to release Kubernetes overall, to make it safer to release Kubernetes, as well as the working group CATE's infra who's been hard at work. One, you'll hear more about the CATEs.gcr.io cut over from Google infrastructure to community infrastructure during the conference. You'll hear more about the image promotion process, how we're handling artifacts moving forward as we now own those artifacts in community infrastructure. And then finally, the working group naming was formed. This ties back into the thought of making sure that this project is inclusive and being thoughtful about the language that we use across both our code bases and our content overall. So stay tuned for more details on that later in the conference and as well as a community meeting from a new initiative that's happening on kind of the wider community across LF, CNCF, standards bodies, different companies. So stay tuned for that. Thanks everyone, later.


Today guys I bring you a new world video showcasing all known legendary lifestaffs in the game. I will mention a lot of these haven't been obtained yet as well as some of the images are placeholders, but in terms of the weapon stats and how to obtain it's all here guys so let's go. How's it going people my name is DPJ and if you enjoyed the video leave a like really helps out and if you like what you see and want to see more be sure to subscribe. Ok so today I bring you a video showcasing all known legendary lifestaffs in the game and how they are obtained, now like I said some of the images are placeholder images also some of the weapons haven't been obtained yet, those weapons I'm hoping you can help me out with. So let's go. First up guys we have the Divine Devotion. So this legendary is an exclusive drop to the Lazarus Instrumentality Expedition boss known as Scylla. Next up guys we have the Wheel of the Ancient. So this legendary seems exclusive to name bosses within the main expeditions. Those expeditions are the Garden of Genesis, the Lazarus Instrumentality and the Depths. Next up guys we have the Higher Purpose. So this legendary is an exclusive drop from the Garden of Genesis Expedition boss known as Alluvia Mildercare Taker. Next up guys we have the Lifebinder. So this legendary is an outpost rush, tier 5 chest reward. So you obviously need to be a level 60 to take part in this PvP battleground style of 20v20 mode. Once you complete it you have a chance to drop in from the tier 5 chest. Next up guys we have the Wind Singer. So this legendary you have to craft. It requires a station of an Alchemist tier 5, it requires an Arcane at a level of 190, trade skill XP needs to be 7,285 and territory is standing at 141. Ok so the following three lifestuffs the world drops across the board, meaning once you reach I believe it's a level 40 to 50, these will be added into the loop pool of most named bosses across the world. Those are the Grotto's Seed, the Hidden Depths and the Giver's Green Gift. Ok so the following four are unknown drops meaning we don't know how these are obtained as of right now so if you have any clue on any of these and how they are obtained let me know and I'll edit the video description. Ok so those are the War Mage's Life Staff, the Invaders' Unholy Staff, the Hope and the Shaman Queen. So yes guys those four lifestuffs are at the moment we don't know how they are obtained. But there we have it guys all legendary lifestuffs in New World as of right now. If you guys enjoyed the video leave a like, it really helps out if you're new around here and want to see more be sure to subscribe and if you never want to miss a video I upload you can turn notifications on by hitting that bell button but guys thanks as always for stopping by and hopefully I will see you on that next one.


Look at this slide. How long will it take for computers to have the same power as the human brain? Same thing, right? What Hemingway referred to gradually then suddenly. Not much happens for a long time, and we don't think it's real, but then we have this, right? The last few period is just boom and we're there. And that is exponential. So think about your future as a content creator, or as a publisher, or as a media company, is going to be exponentially different. And the good news is this. I've been in the media business doing media stuff since 1995. I used to be a musician and producer. Thankfully, that was before the internet, so you can't find any of it. But in any case, technology came along and disrupted everything, music, films, television, publishing, financial, Bitcoin, the story goes on. But now in media, we're coming out of the valley of death. The valley of death is the valley where we couldn't figure out the old system is dead, the new one isn't here yet. We're coming out of that now. There's a lot of reasons for that, but the primary reason is mobile. Because finally, there's a mechanism to get, to produce, and now very soon to pay. And also, the mobile is personal. We're not going to accept the garbage and the junk from television advertising on our mobile screen. We're going to have to be better than that. So what happens here is clearly mind boggling changes. Deloitte predicts a $62 billion market for on-demand content. I mean, remember all the stories last year or a couple of years ago about how people just are not willing to pay for content, right? Don't believe it. They will pay, but it has to be absolutely irresistible. If Spotify would cost a pound a week, or better yet, two pounds a month, would there be a single person who wouldn't have a service like this? Because then you could find all kinds of ways of paying for it. And think about that for a second. If the New York Times wasn't $350 a year, how many subscribers would they have? $20 a year? $14 million subscribers? Netflix is the sex story here, right? This is the number one story. I think there aren't actually that many people in Ireland who are subscribing, only like $200K, I think, something like that. But internationally speaking, if the studios would give a license to Netflix, anywhere, these guys would have 300, 400, 500 million subscribers. Talk about willingness to buy for value.